Thai Nakarin Hospital Public Co. Ltd.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR carries a market capitalization of 5.40B, placing it among publicly traded companies globally. Its enterprise value stands at 3.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR has 180.00M shares outstanding.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR trades at a trailing price-to-earnings ratio of 16.55. The price-to-sales ratio is 1.99, and the price-to-book ratio stands at 1.56.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR trades at an EV/EBITDA multiple of 6.56 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.03 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Thai Nakarin Hospital Public Co. Ltd. NVDR trades at an EV/FCF ratio of 23.67, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 3.51B versus a market cap of 5.40B, with the gap driven by net debt and cash on the balance sheet.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR maintains a current ratio of 5.75, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.04, indicating conservative leverage, while an interest coverage ratio of 15,295.46 demonstrates strong ability to service its debt obligations.

Over the twelve months ended April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR posted a return on equity (ROE) of 9.70, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.23 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.46, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.70, useful for judging operating efficiency across full business cycles. The company generates approximately 1.93M in revenue per employee across its workforce of 1,408.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 32.15 indicates how many times Thai Nakarin Hospital Public Co. Ltd. NVDR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR recorded 83.42M in income tax expense. That works out to an effective tax rate of 20.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 409.72M, leaving 326.31M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR's stock has declined approximately 13.74% over the past 52 weeks. The 50-day moving average sits at 28.45, while the 200-day moving average is 30.06.

Over the twelve months ended April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR generated 2.72B in revenue and converted that into 326.31M in net income, yielding earnings per share of 1.81. EBITDA reached 535.34M, while operating income came in at 388.75M.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR holds 1.89B in cash and equivalents against 1.32M in total debt, resulting in a net debt position of -1.20B. Total book value stands at 3.47B, with working capital of 1.79B providing operational flexibility.

Thai Nakarin Hospital Public Co. Ltd. NVDR produced 452.34M in operating cash flow over the twelve months ended April 30, 2026. After subtracting -304.10M in capital expenditures, free cash flow totaled 148.24M - equivalent to 0.82 per share.

Over the twelve months ended April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR posted a gross margin of 24.32, reflecting its pricing power and cost economics. The operating margin of 14.32 and net profit margin of 12.02 provide insight into operational efficiency.

Over the twelve months ended April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 2.75, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.01, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Thai Nakarin Hospital Public Co. Ltd. NVDR shareholders.

As of April 30, 2026, Thai Nakarin Hospital Public Co. Ltd. NVDR has an Altman Z-Score of 9.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.